Skip to main content
Signal8

Longcor Jarrod

SEC insider (Form 3/4/5 filer). CIK 0001545565. Chief Operating Officer at Cellectar Biosciences, Inc. (CLRB). 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 7, 2026. Located in FLORHAM PARK, NJ.

Companies Longcor Jarrod has filed insider reports for

  • Cellectar Biosciences, Inc. (CLRB): Officer, Chief Operating Officer
Longcor Jarrod profile photo

Longcor Jarrod

CIK: 0001545565

Transaction Breakdown

Open Market Buys (P)3 (60.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Cellectar Biosciences, Inc. logo
CLRB

Cellectar Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Cellectar Biosciences, Inc. logo
    CLRB

    Cellectar Biosciences, Inc.

    Jul 7, 2026
    Award

    Stock option (right to buy)

    Direct
    118K shares-
  • Cellectar Biosciences, Inc. logo
    CLRB

    Cellectar Biosciences, Inc.

    May 7, 2026
    Purchase
    Direct
    8.7K shares at avg. $2.88$25K
  • Cellectar Biosciences, Inc. logo
    CLRB

    Cellectar Biosciences, Inc.

    Jul 2, 2025
    Purchase
    Direct
    10K shares at avg. $4.99$50K
  • Cellectar Biosciences, Inc. logo
    CLRB

    Cellectar Biosciences, Inc.

    Feb 14, 2025
    Award

    Stock option (right to buy)

    Direct
    500K shares-
  • Cellectar Biosciences, Inc. logo
    CLRB

    Cellectar Biosciences, Inc.

    Jan 10, 2025
    Purchase
    Direct
    30K shares at avg. $0.28$8K

1-5 of 5